XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents ($355 and $333 related to VIEs) $ 2,776 $ 2,829
Marketable securities ($38 and $59 related to VIEs) 53 130
Accounts receivable, net ($173 and $92 related to VIEs) 1,083 921
Contract assets ($127 and $130 related to VIEs) 1,434 1,138
Other current assets ($25 and $32 related to VIEs) 126 157
Total current assets 5,472 5,175
Noncurrent assets    
PP&E, net ($42 and $46 related to VIEs) 479 494
Investments 4,822 2,828
Other assets ($17 and $17 related to VIEs) 695 646
Total noncurrent assets 5,996 3,968
Total assets 11,468 9,143
Current liabilities    
Accounts payable ($252 and $233 related to VIEs) 1,502 1,220
Contract liabilities ($302 and $278 related to VIEs) 1,396 684
Accrued salaries, wages and benefits ($18 related to VIEs in both periods) 618 640
Other accrued liabilities ($43 and $37 related to VIEs) 268 527
Total current liabilities 3,784 3,071
Long-term debt 1,070 1,104
Deferred taxes 898 468
Other noncurrent liabilities 489 508
Commitments and contingencies
Shareholders’ equity    
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 161,169,582 and 169,228,759 shares in 2025 and 2024, respectively 2 2
APIC 825 1,174
AOCI (283) (351)
Retained earnings 4,642 3,124
Total shareholders’ equity 5,186 3,949
NCI 41 43
Total equity 5,227 3,992
Total liabilities and equity $ 11,468 $ 9,143